Want to join the conversation?
Insurance underwriter $TRV reported 3Q15 diluted earnings of $2.97 per share, which was a growth of 10% from the prior year quarter. Net and operating income grew 1% and 3% respectively from 3Q14. Total revenues fell 1% from last year to $6.794Bil.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.